Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
Completed · Phase 3
Conditions studied: Opioid-Related Disorders
In brief
The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.
Key facts
- Study ID
- NCT00078130
- Run by
- University of Pennsylvania
- People needed
- 223
- Starts
- 2003-07-01
- Expected to finish
- 2006-01-01
- Last updated by the study team
- 2017-01-12
Who can join
Age: 14 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mercy Hospital — Portland, Maine, United States
- Mountain Manor — Baltimore, Maryland, United States
- ASAP — Albuquerque, New Mexico, United States
- Duke Addictions Program — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.